Casdin Capital, LLC Ovid Therapeutics Inc. Transaction History

Casdin Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$6.53 - $9.82 $1.04 Million - $1.57 Million	-160,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$6.12 - $12.31 $290,700 - $584,725	-47,500 Reduced 22.89%	160,000 $1.58 Million
Q3 2017 Nov 14, 2017	BUY	$5.32 - $9.77 $1.1 Million - $2.03 Million	207,500	207,500 $1.78 Million

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $67.6M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.